Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3C3 | Q8NEB9 | 10/20 | 1.00 |
| ▸ | PIK3CA | P42336 | 8/20 | 1.00 |
| ▸ | PIK3R1 | P27986 | 5/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 1.00 |
| ▸ | MAPT | P10636 | 3/20 | 1.00 |
| ▸ | RECQL | P46063 | 3/20 | 1.00 |
| ▸ | MTOR | P42345 | 3/20 | 1.00 |
| ▸ | THRB | P10828 | 2/20 | 1.00 |
| ▸ | MEN1 | O00255 | 2/20 | 1.00 |
| ▸ | HPGD | P15428 | 2/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 2/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 1.00 |
| ▸ | PRKDC | P78527 | 2/20 | 1.00 |
| ▸ | PIK3CD | O00329 | 2/20 | 1.00 |
| ▸ | PIK3CG | P48736 | 2/20 | 1.00 |
| ▸ | ABCC4 | O15439 | 1/20 | 1.00 |
| ▸ | ABCB11 | O95342 | 1/20 | 1.00 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 1.00 |
| ▸ | PIK3CB | P42338 | 1/20 | 1.00 |
| ▸ | PI4KA | P42356 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Wortmannin SCHEMBL1147299 | 1.00 | PIK3C3 (1.00) | PIK3C3PIK3CAPIK3R1ALDH1A1MAPT | |
| Wortmannin SCHEMBL19737003 | 1.00 | PIK3C3 (1.00) | PIK3C3PIK3CAPIK3R1ALDH1A1MAPT | |
| Wortmannin SCHEMBL12650003 | 1.00 | PIK3C3 (1.00) | PIK3C3PIK3CAPIK3R1ALDH1A1MAPT | |
| Wortmannin SCHEMBL4896797 | 1.00 | PIK3C3 (1.00) | PIK3C3PIK3CAPIK3R1ALDH1A1MAPT | |
| Wortmannin SCHEMBL18022829 | 1.00 | PIK3C3 (1.00) | PIK3C3PIK3CAPIK3R1ALDH1A1MAPT | |
| Wortmannin SCHEMBL12162186 | 1.00 | PIK3C3 (1.00) | PIK3C3PIK3CAPIK3R1ALDH1A1MAPT | |
| Wortmannin SCHEMBL14174545 | 1.00 | PIK3C3 (1.00) | PIK3C3PIK3CAPIK3R1ALDH1A1MAPT | |
| Wortmannin SCHEMBL14233191 | 1.00 | PIK3C3 (1.00) | PIK3C3PIK3CAPIK3R1ALDH1A1MAPT | |
| Wortmannin SCHEMBL13166020 | 1.00 | PIK3C3 (1.00) | PIK3C3PIK3CAPIK3R1ALDH1A1MAPT | |
| Wortmannin SCHEMBL4530 | 1.00 | PIK3C3 (1.00) | PIK3C3PIK3CAPIK3R1ALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 21277 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3841097-B1 | 2,6-BIS(((1H-BENZO[D]IMIDAZOL-2-YL)THIO)METHYL)PYRIDINE AND N2,N6-DIBENZYLPYRIDINE-2,6-DICARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS PHOSPHOINOSITIDE 3-KINASE (PI3K) INHIBITORS FOR TREATING CANCER | BIOMEDICAL RES FOUNDATION OF THE ACADEMY OF ATHENS BRFAA (GR) | 2026-05-20 | — | — | EP | claimed |
| US-20260130949-A1 | PANCREATIC CELLS FOR TREATING DIABETES AND METHODS OF GENERATING THE SAME | Seraxis, Inc. (US) | 2026-05-14 | — | — | US | claimed |
| EP-4739678-A2 | AGE-MODULATING COMPOUNDS AND METHODS FOR MAKING AGE-MODULATED CELLS | Memorial Sloan Kettering Cancer Center (US) | 2026-05-13 | — | — | EP | claimed |
| CN-122028940-A | PI4K inhibitor and application thereof | 清华大学 | 2026-05-12 | — | — | CN | claimed |
| CN-122028920-A | Method for treating hematological cancer | 丹娜-法伯癌症研究院 | 2026-05-12 | — | — | CN | claimed |
| US-20260125647-A1 | AGE-MODULATING COMPOUNDS AND METHODS FOR MAKING AGE-MODULATED CELLS | MEMORIAL SLOAN-KETTERING CANCER CENTER (US) | 2026-05-07 | — | — | US | claimed |
| US-20260102500-A1 | PKC INHIBITORS FOR THE TREATMENT OF SEPTIC CHOLESTASIS WITH POLYMETHINE DYE TARGETING | SMARTDYELIVERY GMBH (DE) | 2026-04-16 | — | — | US | claimed |
| US-20260097028-A1 | Methods of Treating Myeloproliferative Neoplasms | KARTOS THERAPEUTICS INC (US) | 2026-04-09 | — | — | US | claimed |
| US-20260090969-A1 | COMPOSITIONS THAT PROTECT CELLS FROM OXIDATIVE AND MITOCHONDRIAL STRESS | Nuchido Limited (GB) | 2026-04-02 | — | — | US | claimed |
| US-20260077047-A1 | CANCER THERAPY | Turbine Simulated Cell Technologies Ltd (GB) | 2026-03-19 | — | — | US | claimed |
| WO-1998055602-A9 | SCREENING FOR PHOSPHATIDYLINOSITOL RELATED-KINASE INHIBITORS | MAYO FOUNDATION (US) | 1999-04-08 | — | — | WO | claimed |
| WO-1998055602-A1 | SCREENING FOR PHOSPHATIDYLINOSITOL RELATED-KINASE INHIBITORS | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) | 1998-12-10 | — | — | WO | claimed |
| WO-1998051702-A1 | METHODS AND COMPOSITIONS FOR DESTRUCTION OF SELECTED PROTEINS | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 1998-11-19 | — | — | WO | claimed |
| EP-0862622-A1 | RAC-PROTEINE KINASE AS THERAPEUTIC AGENT OR IN DIAGNOSTICS | Novartis AG (CH) | 1998-09-09 | — | — | EP | claimed |
| WO-1998032864-A2 | NOVEL LIPID KINASE | LUDWIG INSTITUTE FOR CANCER RESEARCH (GB) | 1998-07-30 | — | — | WO | claimed |
| WO-1997018303-A1 | RAC-PROTEINE KINASE AS THERAPEUTIC AGENT OR IN DIAGNOSTICS | NOVARTIS AG (CH) | 1997-05-22 | — | — | WO | claimed |
| WO-1997015658-A1 | WORTMANNIN PHOSPHOINOSITIDE 3-KINASE INTERACTION SITE | LUDWIG INSTITUTE FOR CANCER RESEARCH (CH) | 1997-05-01 | — | — | WO | claimed |
| EP-0758232-A1 | METHODS FOR MODULATING T CELL RESPONSES BY MANIPULATING INTRACELLULAR SIGNAL TRANSDUCTION | THE UNITED STATES OF AMERICA as represented by THE SECRETARY OF THE NAVY (US) | 1997-02-19 | — | — | EP | claimed |
| WO-1995029673-A1 | METHODS FOR MODULATING T CELL RESPONSES BY MANIPULATING INTRACELLULAR SIGNAL TRANSDUCTION | THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY OF THE NAVY (US) | 1995-11-09 | — | — | WO | claimed |
| EP-0610519-A1 | ANTI-HIV DRUG | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1994-08-17 | — | — | EP | claimed |